Page 1 | Search Results | Diabetes Care | American Diabetes Association

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Comment on Almurdhi et al. Reduced Lower-Limb Muscle Strength and Volume in Patients With Type 2 Diabetes in Relation to Neuropathy, Intramuscular Fat, and Vitamin D Levels. Diabetes Care 2016;39:441–447

Guillaume Treiber, Laurence Baillet-Blanco, Marie Hugo, Emilie Pupier, Isabelle Redonnet-Vernhet, Sophie Cambos, Vincent Rigalleau

Diabetes Care 2016;39(10):e183

https://doi.org/10.2337/dc16-1063

Published: 13 September 2016

View articletitled, Comment on Almurdhi et al. Reduced Lower-Limb Muscle Strength and Volume in Patients With Type 2 Diabetes in Relation to Neuropathy, Intramuscular Fat, and Vitamin D Levels. Diabetes Care 2016;39:441–447

Journal Articles

Response to Comment on Almurdhi et al. Reduced Lower-Limb Muscle Strength and Volume in Patients With Type 2 Diabetes in Relation to Neuropathy, Intramuscular Fat, and Vitamin D Levels. Diabetes Care 2016;39:441–447

Monirah M. Almurdhi, Neil D. Reeves, Frank L. Bowling, Andrew J.M. Boulton, Maria Jeziorska, Rayaz A. Malik

Diabetes Care 2016;39(10):e184–e185

https://doi.org/10.2337/dci16-0020

Published: 13 September 2016

View articletitled, Response to Comment on Almurdhi et al. Reduced Lower-Limb Muscle Strength and Volume in Patients With Type 2 Diabetes in Relation to Neuropathy, Intramuscular Fat, and Vitamin D Levels. Diabetes Care 2016;39:441–447

Journal Articles

Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes

Jennifer L. Sherr, Katrina J. Ruedy, Nicole C. Foster, Claude A. Piché, Hélène Dulude, Michael R. Rickels, William V. Tamborlane, Kathleen E. Bethin, Linda A. DiMeglio, Larry A. Fox, R. Paul Wadwa, Desmond A. Schatz, Brandon M. Nathan, Santica M. Marcovina, Emmanouil Rampakakis, Linyan Meng, Roy W. Beck, for the T1D Exchange Intranasal Glucagon Investigators

Diabetes Care 2016;39(4):555–562

https://doi.org/10.2337/dc15-1606

Published: 16 February 2016

View articletitled, Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes

Includes: Supplementary data

Journal Articles

Reduced Lower-Limb Muscle Strength and Volume in Patients With Type 2 Diabetes in Relation to Neuropathy, Intramuscular Fat, and Vitamin D Levels

Monirah M. Almurdhi, Neil D. Reeves, Frank L. Bowling, Andrew J.M. Boulton, Maria Jeziorska, Rayaz A. Malik

Diabetes Care 2016;39(3):441–447

https://doi.org/10.2337/dc15-0995

Published: 06 January 2016

View articletitled, Reduced Lower-Limb Muscle Strength and Volume in Patients With Type 2 Diabetes in Relation to Neuropathy, Intramuscular Fat, and Vitamin D Levels

Journal Articles

Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study

Michael R. Rickels, Katrina J. Ruedy, Nicole C. Foster, Claude A. Piché, Hélène Dulude, Jennifer L. Sherr, William V. Tamborlane, Kathleen E. Bethin, Linda A. DiMeglio, R. Paul Wadwa, Andrew J. Ahmann, Michael J. Haller, Brandon M. Nathan, Santica M. Marcovina, Emmanouil Rampakakis, Linyan Meng, Roy W. Beck

Diabetes Care 2016;39(2):264–270

https://doi.org/10.2337/dc15-1498

Published: 17 December 2015

View articletitled, Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study

Includes: Supplementary data

Journal Articles

Systemic Oxidative Stress Is Associated With Lower Aerobic Capacity and Impaired Skeletal Muscle Energy Metabolism in Patients With Metabolic Syndrome

Takashi Yokota, MD, Shintaro Kinugawa, MD, Mayumi Yamato, PHD, Kagami Hirabayashi, MD, Tadashi Suga, PHD, Shingo Takada, MS, Kuniaki Harada, PHD, Noriteru Morita, PHD, Noriko Oyama-Manabe, MD, Yasuka Kikuchi, MD, Koichi Okita, MD, Hiroyuki Tsutsui, MD

Diabetes Care 2013;36(5):1341–1346

https://doi.org/10.2337/dc12-1161

Published: 13 April 2013

View articletitled, Systemic Oxidative Stress Is Associated With Lower Aerobic Capacity and Impaired Skeletal Muscle Energy Metabolism in Patients With Metabolic Syndrome

Includes: Supplementary data

Journal Articles

A 4-mm Needle Reduces the Risk of Intramuscular Injections Without Increasing Backflow to Skin Surface in Lean Diabetic Children and Adults

Niels H. Birkebaek, MD, PHD, Jan Solvig, MD, Birtha Hansen, CAND CUR, Christina Jorgensen, MSC PHARM, Jorgen Smedegaard, MD, Jens S. Christiansen, MD, DMSC

Diabetes Care 2008;31(9):e65

https://doi.org/10.2337/dc08-0977

Published: 01 September 2008

View articletitled, A 4-mm Needle Reduces the Risk of Intramuscular Injections Without Increasing Backflow to Skin Surface in Lean Diabetic Children and Adults

Meeting Abstracts

Short needles (8 mm) reduce the risk of intramuscular injections in children with type 1 diabetes.

N Tubiana-Rufi, N Belarbi, L Du Pasquier-Fediaevsky, M Polak, B Kakou, L Leridon, M Hassan, P Czernichow

Diabetes Care 1999;22(10):1621–1625

https://doi.org/10.2337/diacare.22.10.1621

Published: 01 October 1999

View articletitled, Short needles (8 mm) reduce the risk of intramuscular injections in children with type 1 diabetes.

Journal Articles

Subcutaneous or Intramuscular Injections of Insulin in Children: Are we injecting where we think we are?

Michel Polak, MD, PHD, Marta Beregszaszi, MD, Nadia Belarbi, MD, Karim Benali, MD, Max Hassan, MD, Paul Czernichow, MD, Nadia Tubiana-Rufi, MD

Diabetes Care 1996;19(12):1434–1436

https://doi.org/10.2337/diacare.19.12.1434

Published: 01 December 1996

View articletitled, Subcutaneous or Intramuscular Injections of Insulin in Children: Are we injecting where we think we are?

Journal Articles

Hypoglycemia Risk During Exercise After Intramuscular Injection of Insulin in Thigh in IDDM

Anders Frid, MD, Jan Östman, MD, Birgitta Linde, MD

Diabetes Care 1990;13(5):473–477

https://doi.org/10.2337/diacare.13.5.473

Published: 01 May 1990

View articletitled, Hypoglycemia Risk During Exercise After Intramuscular Injection of Insulin in Thigh in IDDM

Journal Articles

Variation in Absorption of NPH Insulin Due to Intramuscular Injection

Allan Vaag, MD, Aase Handberg, MD, Mogens Lauritzen, Msc, Jan Erik Henriksen, MD, Karen Damgaard Pedersen, MD, PhD, Henning Beck-Nielsen, MD, PhD

Diabetes Care 1990;13(1):74–76

https://doi.org/10.2337/diacare.13.1.74

Published: 01 January 1990

View articletitled, Variation in Absorption of NPH Insulin Due to Intramuscular Injection

Journal Articles

Effects of Accidental Intramuscular Injection on Insulin Absorption in IDDM

Anders Frid, MD, R Gunnarsson, MD, P Güntner, MD, B Linde, MD

Diabetes Care 1988;11(1):41–45

https://doi.org/10.2337/diacare.11.1.41

Published: 01 January 1988

View articletitled, Effects of Accidental Intramuscular Injection on Insulin Absorption in IDDM

Journal Articles

Free-Insulin Profiles After Intraperitoneal, Intramuscular, and Subcutaneous Insulin Administration

P Micossi, MD, M Cristallo, MD, M C Librenti, MD, G Petrella, MD, G Galimberti, MD, M Melandri, MD, L Monti, MD, P Spotti, MD, M Scavini, MD, V Di Carlo, MD, G Pozza, MD

Diabetes Care 1986;9(6):575–578

https://doi.org/10.2337/diacare.9.6.575

Published: 01 November 1986

View articletitled, Free-Insulin Profiles After Intraperitoneal, Intramuscular, and Subcutaneous Insulin Administration

Journal Articles

Pharmacokinetics and Bioavailability of Injected Glucagon: Differences Between Intramuscular, Subcutaneous, and Intravenous Administration

Ingrid Mühlhauser, M.D., Jutta Koch, M.D., Michael Berger, M.D.

Diabetes Care 1985;8(1):39–42

https://doi.org/10.2337/diacare.8.1.39

Published: 01 January 1985

View articletitled, Pharmacokinetics and Bioavailability of Injected Glucagon: Differences Between Intramuscular, Subcutaneous, and Intravenous Administration

Update search

NARROW

Format

Journal

Article Type

Topics

Issue Section

Date

Availability

Comment on Almurdhi et al. Reduced Lower-Limb Muscle Strength and Volume in Patients With Type 2 Diabetes in Relation to Neuropathy, Intramuscular Fat, and Vitamin D Levels. Diabetes Care 2016;39:441–447

Response to Comment on Almurdhi et al. Reduced Lower-Limb Muscle Strength and Volume in Patients With Type 2 Diabetes in Relation to Neuropathy, Intramuscular Fat, and Vitamin D Levels. Diabetes Care 2016;39:441–447

Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes

Reduced Lower-Limb Muscle Strength and Volume in Patients With Type 2 Diabetes in Relation to Neuropathy, Intramuscular Fat, and Vitamin D Levels

Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study

Systemic Oxidative Stress Is Associated With Lower Aerobic Capacity and Impaired Skeletal Muscle Energy Metabolism in Patients With Metabolic Syndrome

A 4-mm Needle Reduces the Risk of Intramuscular Injections Without Increasing Backflow to Skin Surface in Lean Diabetic Children and Adults

Short needles (8 mm) reduce the risk of intramuscular injections in children with type 1 diabetes.

Subcutaneous or Intramuscular Injections of Insulin in Children: Are we injecting where we think we are?

Hypoglycemia Risk During Exercise After Intramuscular Injection of Insulin in Thigh in IDDM

Variation in Absorption of NPH Insulin Due to Intramuscular Injection

Effects of Accidental Intramuscular Injection on Insulin Absorption in IDDM

Free-Insulin Profiles After Intraperitoneal, Intramuscular, and Subcutaneous Insulin Administration

Pharmacokinetics and Bioavailability of Injected Glucagon: Differences Between Intramuscular, Subcutaneous, and Intravenous Administration

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Update search

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only